课题基金 / 基金详情

Metabolic Regulation of Toll-like Receptor Agonist Therapy in Leukemia

Metabolic Regulation of Toll-like Receptor Agonist Therapy in Leukemia
Toll 样受体激动剂治疗白血病的代谢调节
批准号:
170526
负责人:
Spaner David E
金额:
$27.73万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2008
资助国家:
加拿大
项目状态:
已结题
起止时间:
2008-09-01 至 2011-09-01

项目摘要

项目成果

Spaner David E的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Chemotherapy does not cure most cancers. However, the results with chemotherapy may be improved with treatments that increase the ability of the immune system to kill cancer cells (or immunotherapy). We have found that a new agent (called S28690), which
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Understanding the role of type 1 interferon in resistance to cancer immunotherapy
Targeting Interferon-beta in leukemia immunotherapy
Improving Glucocorticoid Therapy in Leukemia
国内基金
海外基金
中国北方人群肺癌患者Cancer/Testis抗原表达谱绘制表位鉴定及功能性抗原特异性CTL制备研究
  • 批准号:
    81673007
  • 项目类别:
    面上项目
  • 资助金额:
    54.0万元
  • 批准年份:
    2016
  • 负责人:
    金时
  • 依托单位: